The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. Issue 8 (13th January 2019)
- Record Type:
- Journal Article
- Title:
- The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis. Issue 8 (13th January 2019)
- Main Title:
- The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
- Authors:
- Villanueva, Francisco
Araya, Hector
Briceño, Pedro
Varela, Nelson
Stevenson, Andres
Jerez, Sofia
Tempio, Fabian
Chnaiderman, Jonas
Perez, Carola
Villarroel, Milena
Concha, Emma
Khani, Farzaneh
Thaler, Roman
Salazar‐Onfray, Flavio
Stein, Gary S
van Wijnen, Andre J.
Galindo, Mario - Abstract:
- Abstract: Osteosarcomas are bone tumors that frequently metastasize to the lung. Aberrant expression of the transcription factor, runt‐related transcription factor 2 (RUNX2), is a key pathological feature in osteosarcoma and associated with loss of p53 and miR‐34 expression. Elevated RUNX2 may transcriptionally activate genes mediating tumor progression and metastasis, including the RUNX2 target gene osteopontin ( OPN/SPP1 ). This gene encodes a secreted matricellular protein produced by osteoblasts to regulate bone matrix remodeling and tissue calcification. Here we investigated whether and how the RUNX2/OPN axis regulates lung metastasis of osteosarcoma. Importantly, RUNX2 depletion attenuates lung metastasis of osteosarcoma cells in vivo. Using next‐generation RNA‐sequencing, protein‐based assays, as well as the loss‐ and gain‐of‐function approaches in selected osteosarcoma cell lines, we show that osteopontin messenger RNA levels closely correlate with RUNX2 expression and that RUNX2 controls the levels of secreted osteopontin. Elevated osteopontin levels promote heterotypic cell–cell adhesion of osteosarcoma cells to human pulmonary microvascular endothelial cells, but not in the presence of neutralizing antibodies. Collectively, these findings indicate that the RUNX2/OPN axis regulates the ability of osteosarcoma cells to attach to pulmonary endothelial cells as a key step in metastasis of osteosarcoma cells to the lung. Abstract : In the present study, we examined theAbstract: Osteosarcomas are bone tumors that frequently metastasize to the lung. Aberrant expression of the transcription factor, runt‐related transcription factor 2 (RUNX2), is a key pathological feature in osteosarcoma and associated with loss of p53 and miR‐34 expression. Elevated RUNX2 may transcriptionally activate genes mediating tumor progression and metastasis, including the RUNX2 target gene osteopontin ( OPN/SPP1 ). This gene encodes a secreted matricellular protein produced by osteoblasts to regulate bone matrix remodeling and tissue calcification. Here we investigated whether and how the RUNX2/OPN axis regulates lung metastasis of osteosarcoma. Importantly, RUNX2 depletion attenuates lung metastasis of osteosarcoma cells in vivo. Using next‐generation RNA‐sequencing, protein‐based assays, as well as the loss‐ and gain‐of‐function approaches in selected osteosarcoma cell lines, we show that osteopontin messenger RNA levels closely correlate with RUNX2 expression and that RUNX2 controls the levels of secreted osteopontin. Elevated osteopontin levels promote heterotypic cell–cell adhesion of osteosarcoma cells to human pulmonary microvascular endothelial cells, but not in the presence of neutralizing antibodies. Collectively, these findings indicate that the RUNX2/OPN axis regulates the ability of osteosarcoma cells to attach to pulmonary endothelial cells as a key step in metastasis of osteosarcoma cells to the lung. Abstract : In the present study, we examined the functional role of runt‐related transcription factor 2 (RUNX2) in lung metastasis. Our results indicate that RUNX2 regulates secretion of osteopontin, which promotes cell–cell adhesion between osteosarcoma cells and pulmonary endothelial cells. Thus, the RUNX2/OPN axis regulates late steps of lung metastasis by controlling the metastatic potential of osteosarcoma cells. … (more)
- Is Part Of:
- Journal of cellular physiology. Volume 234:Issue 8(2019:Aug.)
- Journal:
- Journal of cellular physiology
- Issue:
- Volume 234:Issue 8(2019:Aug.)
- Issue Display:
- Volume 234, Issue 8 (2019)
- Year:
- 2019
- Volume:
- 234
- Issue:
- 8
- Issue Sort Value:
- 2019-0234-0008-0000
- Page Start:
- 13659
- Page End:
- 13679
- Publication Date:
- 2019-01-13
- Subjects:
- cancer -- cell adhesion -- metastasis -- osteopontin -- osteosarcoma
Physiology -- Periodicals
Cell physiology -- Periodicals
571.6 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4652 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcp.28046 ↗
- Languages:
- English
- ISSNs:
- 0021-9541
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.020000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26755.xml